{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:16:15Z","timestamp":1786986975610,"version":"build-2736575974"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":446,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100019089","name":"Alberta Precision Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007582","name":"Alberta Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cmi.2022.08.025","type":"journal-article","created":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T02:12:07Z","timestamp":1662775927000},"page":"247-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals"],"prefix":"10.1016","volume":"29","author":[{"given":"William","family":"Stokes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison A.","family":"Venner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Buss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Tipples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron M.","family":"Berenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2022.08.025_bib2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/JCM.01535-20","article-title":"Direct comparison of SARS-CoV-2 analytical limits of detection across seven molecular assays","volume":"58","author":"Fung","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2022.08.025_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2020.115200","article-title":"Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type","volume":"99","author":"Lephart","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2022.08.025_bib4","article-title":"Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection","volume":"3","author":"Dinnes","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2022.08.025_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/clinchem\/hvab145","article-title":"Wide variation in threshold cycle values clouds the interpretation of SARS-CoV-2 infectiousness","volume":"68","author":"Stokes","year":"2021","journal-title":"Clin Chem"},{"key":"10.1016\/j.cmi.2022.08.025_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10096-020-03972-y","article-title":"Combined throat\/nasal swab sampling for SARS-CoV-2 is equivalent to nasopharyngeal sampling","volume":"40","author":"Vlek","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2022.08.025_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12866-021-02087-4","article-title":"Combined oropharyngeal\/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR","volume":"21","author":"Desmet","year":"2021","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.cmi.2022.08.025_bib8","doi-asserted-by":"crossref","first-page":"28811","DOI":"10.1128\/JCM.02881-20","article-title":"Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS-CoV-2 molecular detection: a systematic review and meta-analysis","volume":"59","author":"Lee","year":"2021","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.cmi.2022.08.025_bib9","first-page":"16","article-title":"Development and validation of reverse transcriptase-PCR assays for the testing of SARS-CoV-2","volume":"6","author":"Pabbaraju","year":"2020","journal-title":"Off. J. Assoc. Med. Microbiol. Infect. Dis. Canada"},{"key":"10.1016\/j.cmi.2022.08.025_bib10","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001372","article-title":"Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19","volume":"70","author":"Stokes","year":"2021","journal-title":"J\u00a0Med Microbiol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22004621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22004621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:34:08Z","timestamp":1761118448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X22004621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1198743X22004621"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2022.08.025","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.04.30.22274189","asserted-by":"object"}]},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2022.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}